Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

Published:2000-11 Issue:9 Volume:86 Page:950-953
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Martı́nez-Marcos Francisco Javier,Garcı́a-Garmendia Jose Luis,Ortega-Carpio Antonio,Fernández-Gómez Juan Manuel,Santos Jose Marı́a,Camacho Crescencio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Antiarrhythmic drug therapy in the management of atrial fibrillation;Ganz;J Cardiovasc Electrophysiol,1997

2. Drug treatment of atrial fibrillation;Hohnloser;Curr Opin Cardiol,1997

3. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm;Falk;Ann Intern Med,1987

4. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation;Donovan;Am J Cardiol,1995

5. Contemporary management of atrial fibrillation;Ukani;Med Clin North Am,1995

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Therapeutic potential of flecainide for cardiac arrhythmias: a short review of studies and clinical recommendations;Journal of Arrhythmology;2024-08-22

3. Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers;International Journal of Translational Medicine;2024-06-03

4. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-06-03

5. Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular;Clínica e Investigación en Arteriosclerosis;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3